RaySearch to present the latest advances in RayStation, RayCare and RayIntelligence at ESTRO 2024
RaySearch will be showcasing its latest software innovations at ESTRO in Glasgow, May 3-6. Attendees will be able to book demonstrations of the treatment planning system RayStation®*, the oncology information system RayCare®*, and the cloud-based oncology analytics system RayIntelligence® during the congress. Demonstrations are booked at booth #500. Additionally, RaySearch will present joint solutions with industry partners IBA, Vision RT, Accuray, GE Healthcare, and Leo Cancer Care.
RayStation demonstrations will include the latest news, such as support for fast automated replanning and automatic import of images directly followed by deep learning image segmentation. The speed of the deep learning image segmentation has been increased and a large range of new deep learning segmentation models, including head-and-neck lymph nodes, has been developed to further boost the efficiency at the clinics. Attendees can also experience a new SRS planning tool for treating multiple tumors simultaneously, which groups tumors per beam to reduce dose to healthy tissue. Within particle therapy planning, emerging technologies such as optimization based on linear energy transfer (LET) and proton arc planning will be highlighted.
RayCare is a next-generation oncology information system designed to be centered around the patient journey and provide one oncology workflow for all clinical staff caring for a patient throughout the course of treatment. At ESTRO, active oncology workflows will be showcased, as well as automation for the full patient journey to promote efficiency and streamlining of patient care throughout the RaySearch product suite. Attendees will be able to experience the new dedicated workspace for treatment course management which supports all user needs in relation to managing the fractionation schedule for treatments including assignment of plans, managing treatment settings, and handling approvals. Further, ongoing work and future plans for RayCare in relation to online adaptive treatments will also be demonstrated.
The cloud-based oncology analytics system RayIntelligence will also be demonstrated during the congress, showcasing the latest version of the system together with dashboards illustrating current and future use cases involving data from RayStation and RayCare combined with treatment outcome data.
Johan Löf, founder and CEO, RaySearch, says: Attending ESTRO and meeting our customers is always one of the highlights of the year. This year I am particularly happy to present our latest developments within online adaptive and several significant partner collaborations. At RaySearch we are convinced that open interfaces and joint collaborations are important for the continued development of radiotherapy.”
Live talks and poster presentations at ESTRO 2024
Jakob Ödén
Title: Thermoradiotherapy optimization: accounting for thermal enhancement for photon and proton therapy
Presentation time: 5 May 2024 at 16:30-17:30 in Hall 3
Christopher Thompson
Title: Robust dose mapping accounting for per-organ deformations uncertainties
Presentation time: 6 May 2024 at 16:45-17:45 in Hall 1
Giovanni Parrella
Title: Benefits and limitations of LET optimization for carbon ion radiotherapy in sacral chordomas
Presentation time: 4 May 2024 at 10:30-11:30 in Hall 3
Jakob Ödén
Title: Beyond a constant proton RBE: Survey on clinical and research activities in Europe and United States
Poster number: 2230
For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
johan.lof@raysearchlabs.com
About RaySearch
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®*. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems.
RaySearch’s software has been sold to over 1,000 clinics in 43 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003. More information is available at raysearchlabs.com.
About RayStation
RayStation®* is a flexible, innovative treatment planning system, chosen by many leading cancer centers worldwide. It combines unique features such as unmatched adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for treatment plan optimization for HDR brachytherapy and external beam therapy with photons, electrons, and protons, as well as helium and carbon ions. RayStation supports a wide range of treatment machines, providing one control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also seamlessly integrates with RayCare®*. By harmonizing the treatment planning, the care of cancer patients worldwide is improved.
About RayCare
The RayCare®* oncology information system (OIS) is designed to support the many complex logistical challenges faced by today’s oncology clinics. RayCare is closely integrated with RayStation®* and provides seamless access to all the powerful planning tools in RayStation and RayCommand®. The system efficiently coordinates activities in radiation therapy and offers advanced features for clinical workflow automation, and adaptive radiation therapy. RayCare responds to the demand from clinics for a more user-friendly and workflow-oriented information system that can support the cancer care of the future.
About RayIntelligence
Data-driven oncology represents a new era in healthcare. RayIntelligence® is an innovative cloud-based oncology analytics system that gives meaning to data, empowering cancer centers to reach new levels of personalized care through insights based on clinical data.
* Subject to regulatory clearance in some markets.
Tags:
